DEBILITATING nerve damage that affects as many as half the country’s diabetes sufferers could be arrested with early detection, according to a world-first trial at the Prince of Wales Hospital.
Dr Arun Krishnan, a neurologist at the hospital and the study’s lead author, believes nerve excitability testing could be used to detect neuropathy in people before any outward signs of damage are exhibited.
He believes that treatments used only in more advanced cases of neuropathy could be effective in these early cases, although they are not used currently because the nerve damage is as yet undiagnosed.
